Join to view full profile
460 W 10th AveColumbus, OH 43210
Phone+1 614-293-5066
Fax+1 614-293-9449
Dr. Hayes is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2001 - 2004
Boston University Medical CenterResidency, Internal Medicine, 1997 - 2000
University of North Carolina at Chapel Hill School of MedicineClass of 1996
Certifications & Licensure
OH State Medical License 2026 - 2028
MS State Medical License 2017 - 2027
NC State Medical License 2004 - 2027
TN State Medical License 2017 - 2027
MA State Medical License 1999 - 2006
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification WebCIS, UNC Health Care, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer Start of enrollment: 2010 Sep 09
- Identification of Gene Expression Signature for Panitumumab Sensitivity in Untreated Locally Advanced SCCHN
- Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2013 Oct 14
Publications & Presentations
PubMed
- Splicing genes as main targets of differential splicing.Torstein Tengs, Thomas LaFramboise, Yossef Baidi, Rameen Beroukhim, Won-Young Choi
G3. 2026-08-14 - Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non-Small Cell Lung Cancer: The Piedmont Study.Joel R Eisner, Gregory M Mayhew, James M Davison, Kirk D Beebe, Yoichiro Shibata
Clinical Cancer Research. 2023-08-15 - 3 citationsSequencing of genes of drug response in tumor DNA and implications for precision medicine in cancer patients.Nancy Gillis, Amy S Etheridge, Sushant A Patil, D Neil Hayes, Michele C Hayward
The Pharmacogenomics Journal. 2023-07-01
Journal Articles
- Identification and Validation of Novel Microenvironment-Based Immune Molecular Subgroups of Head and Neck Squamous Cell Carcinoma: Implications for ImmunotherapyJ Ma, D N Hayes, A Dimitrios Colevas, N Lee, Annals of Oncology
Press Mentions
Next-Generation Sequencing Assay Validated Across Labs, Tumor TypesMay 12th, 2017
Grant Support
- UTHSC K12 Career Development Program in Clinical OncologyUNIVERSITY OF TENNESSEE HEALTH SCI CTR2026–2031
- Specialized RNA analysis center for integrative genomic analysesUNIV OF NORTH CAROLINA CHAPEL HILL2021–2026
- UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation CenterUNIV OF NORTH CAROLINA CHAPEL HILL2019–2026
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
